Narita Takuya, Ishizawa Ai, Inoue Nobuyuki, Uchida Tetsuro, Nakamura Yoshitsugu
Cardiovascular Surgery, Chiba-Nishi General Hospital, Matsudo, Chiba, Japan.
Cardiovascular Surgery, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan.
Ann Thorac Cardiovasc Surg. 2025;31(1). doi: 10.5761/atcs.oa.25-00047.
This study evaluated the midterm outcomes, including adverse aortic events (AAEs), of the "graft insertion technique" (GIT) for left ventricular outflow tract (LVOT) and aortic root reconstruction.
From August 2014 to March 2024, 14 consecutive patients underwent GIT for LVOT and aortic root reconstruction. The indications for surgery were prosthetic valve endocarditis in 9 cases and noninfectious pseudoaneurysm in 5 cases. Among these patients, seven (50.0%) underwent aortic root surgery, while the other seven (50.0%) underwent aortic valve replacement alone or in combination with other procedures without aortic root surgery. Their mean EuroSCORE II was 28.8 ± 17.6.
The mean total operation time was 504 ± 87 min. The mean cardiopulmonary bypass and aortic cross-clamp times were 311 ± 41 and 240 ± 45 min, respectively. Operative mortality occurred in one case (7.1%), and five patients (35.7%) died during the first year of follow-up. No surviving patients experienced recurrent endocarditis. No patients died from cardiovascular events or infections after the second year of follow-up. Furthermore, no AAEs were observed on computed tomography during the follow-up period after hospital discharge.
GIT is a feasible alternative for high-risk cases of redo aortic root surgery.
本研究评估了“移植物植入技术”(GIT)用于左心室流出道(LVOT)和主动脉根部重建的中期结果,包括主动脉不良事件(AAEs)。
2014年8月至2024年3月,连续14例患者接受了GIT进行LVOT和主动脉根部重建。手术适应证为人工瓣膜心内膜炎9例,非感染性假性动脉瘤5例。在这些患者中,7例(50.0%)接受了主动脉根部手术,另外7例(50.0%)单独进行了主动脉瓣置换或与其他未涉及主动脉根部手术的手术联合进行。他们的平均欧洲心脏手术风险评估系统(EuroSCORE)II评分为28.8±17.6。
平均总手术时间为504±87分钟。平均体外循环和主动脉阻断时间分别为311±41分钟和240±45分钟。1例(7.1%)发生手术死亡,5例患者(35.7%)在随访的第一年死亡。没有存活患者发生复发性心内膜炎。随访第二年之后,没有患者死于心血管事件或感染。此外,出院后的随访期间,计算机断层扫描未观察到AAEs。
对于再次进行主动脉根部手术的高危病例,GIT是一种可行的替代方法。